Capecitabine Tablets

Active Ingredients: Capecitabine

Capecitabine Tablets are an antineoplastic drug used to treat certain types of cancer, including colon cancer, breast cancer, and colorectal cancer. It is sometimes prescribed for cancer that has become metastatic. Capecitabine may be used alone or in combination with other chemotherapy treatments.

Capecitabine is classified as a nucleoside metabolic inhibitor and an antineoplastic agent. It is a prodrug, which is converted into fluorouracil within the tumor. It works by interfering with DNA synthesis within the cancer cells.

This medication is produced and exported by AdvaCare Pharma. Capecitabine Tablets is manufactured in our facilities in China, India, and the USA. Our factories comply with WHO rules and regulations, and we regularly inspect these facilities to ensure they meet these high standards.

AdvaCare Pharma manufactures a variety of oncology medications, including Capecitabine Tablets, at GMP-certified facilities. We are committed to producing cost-effective, high-quality cancer treatments that meet the highest industry standards and are readily available to cancer patients worldwide. Our global reach extends to over 65 markets, where we supply our products to distributors, hospitals, pharmacies, NGOs, and government institutions.

What is Capecitabine used for?

Capecitabine may be used to treat cancer that has become metastatic.

How are Capecitabine Tablets used?

This medication has been manufactured to be taken orally. This medicine should be taken with a meal or 30 minutes after eating.

What dose should be taken?

For stage III colon cancer (adjuvant), the usual dose is 1250mg/m², per dose, given twice a day during days 1-14 of a 21-day cycle. Repeat for 8 cycles.

For metastatic colorectal cancer, the usual dose is 1250mg/m², per dose, given twice a day during days 1-14 of a 21-day cycle.

For metastatic breast cancer (refractory or relapsed), the usual dose is 1250mg/m², per dose, given twice a day during days 1-14 of a 21-day cycle. When combined with lapatinib, the dose should be decreased to 1000mg/m²/dose. When combined with neratinib, the dose should be decreased to 750mg/m² per dose.

As with all pharmaceuticals, some unwanted effects can occur from the use of Capecitabine Tablets.

For a comprehensive list of all side effects, consult a doctor or pharmacist.

If any symptom persists or gets worse, or you notice any other symptoms, please call your doctor immediately.

This medicine may harm a fetus if either the mother or father are being treated. For women, use efficient birth control at least 6 months after the last dose of Capecitabine. For me, use effective birth control at least months after your last treatment. If you or your partner become pregnant, inform a doctor as soon as possible. Do not breastfeed while undergoing treatment with this medicine.

Many drugs are known to interact with Capecitabine, so be sure to check with a doctor before beginning treatment.